The tension between growth and profitability is best resolved by understanding your product's "runway" (be it 6 months or 6 years). This single piece of information, often misaligned between teams and leadership, should dictate your strategic focus. The key task is to uncover this true runway.

Unlike traditional contractors paid for hours, Anduril invests its own capital to build products it believes the government needs. This model incentivizes speed and effectiveness, as profit is tied to successful products, not billable hours. This shifts the financial risk from the taxpayer to the company.

Unlike traditional contractors paid for time and materials, Anduril invests its own capital to develop products first. This 'defense product company' model aligns incentives with the government's need for speed and effectiveness, as profits are tied to rapid, successful delivery, not prolonged development cycles.

Many defense startups fail despite superior technology because the government isn't ready to purchase at scale. Anduril's success hinges on identifying when the customer is ready to adopt new capabilities within a 3-5 year window, making market timing its most critical decision factor.

True defensibility comes from successfully navigating successive challenges that weed out competitors. Many have an idea, fewer can build it, even fewer can maintain shipping cadence and distribution, and only a handful can raise capital at scale, leaving a 2-3 horse race.

An analysis of the 20 most successful soft drinks of a decade revealed it took an average of seven years to be considered a success. However, most corporations only give new products a year, or even a single quarter, to prove themselves, killing them prematurely.

The path for biotech entrepreneurs is a long slog requiring immense conviction. Success ("liftoff") isn't just a clinical trial result, but achieving self-sustaining profitability and growth. This high bar means founders may need to persevere through years of market indifference and financing challenges.

Unlike mass manufacturers, defense tech requires flexibility for a high mix of low-volume products. Anduril addresses this by creating a core platform of reusable software, hardware, and sensor components, enabling fast development and deployment of new systems without starting from scratch.

Unlike SaaS, defense and manufacturing startups must build physical products. Investors now scrutinize the "production lag"—the time from contract win to revenue recognition—as a key performance metric. This lag can obscure a company's true health if only looking at top-line contract values.